CNSP
CNS Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$5.11
−0.20%1
Insider buys (3m)
0
Insider sells (3m)
$10.0K
Net value (3m)
+18.7%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Aug 18, 2026 | Fisher Michal · director | Purchase | 2,000 | $5.00 |
| Aug 18, 2026 | Levin Rami · officer: CEO and President | M-Exempt | 4,750 | $0.00 |
| May 20, 2026 | Charles Faith L. · director | Purchase | 7,100 | $4.79 |
| Mar 4, 2026 | Faulkner Eric · officer: Chief Technology Officer | A-Award | 9,500 | $0.00 |
| Mar 4, 2026 | O'Loughlin Steve · officer: Chief Financial Officer | A-Award | 9,500 | $0.00 |
| Jan 2, 2026 | Levin Rami · director, officer: CEO and President | A-Award | 19,000 | $0.00 |
| Nov 19, 2025 | Charles Faith L. · director | A-Award | 1,517 | $12 |
| Nov 19, 2025 | Downs Christopher · officer: Chief Financial Officer | A-Award | 4,881 | $30 |
| Nov 19, 2025 | Gumulka Jerzy · director | A-Award | 1,517 | $12 |
| Nov 19, 2025 | Keyes Jeffry R. · director | A-Award | 1,517 | $12 |
| Nov 19, 2025 | Cockroft Bettina M. · director | A-Award | 1,517 | $12 |
| Nov 19, 2025 | Climaco John M · director, officer: Chief Executive Officer | A-Award | 9,761 | $30 |
| Nov 19, 2025 | Mahery Amy · director | A-Award | 1,517 | $12 |
| Apr 10, 2024 | Cockroft Bettina M. · director | A-Award | 17,500 | $0.00 |
| Apr 10, 2024 | Climaco John M · director, officer: Chief Executive Officer | A-Award | 83,000 | $0.00 |
| Apr 10, 2024 | Charles Faith L. · director | A-Award | 17,500 | $0.00 |
| Apr 10, 2024 | Mahery Amy · director | A-Award | 17,500 | $0.00 |
| Apr 10, 2024 | Keyes Jeffry R. · director | A-Award | 17,500 | $0.00 |
| Apr 10, 2024 | Gumulka Jerzy · director | A-Award | 17,500 | $0.00 |
| Apr 10, 2024 | Evans Carl Anthony · director | A-Award | 17,500 | $0.00 |
| Apr 10, 2024 | Downs Christopher · officer: Chief Financial Officer | A-Award | 40,000 | $0.00 |
| Feb 6, 2024 | Gumulka Jerzy · director | A-Award | 33,333 | $0.30 |
| Feb 6, 2024 | Mahery Amy · director | A-Award | 12,420 | $0.25 |
| Feb 6, 2024 | Gumulka Jerzy · director | Purchase | 33,333 | $0.30 |
| Feb 6, 2024 | Evans Carl Anthony · director | A-Award | 33,333 | $0.30 |
| Feb 6, 2024 | Evans Carl Anthony · director | Purchase | 33,333 | $0.30 |
| Feb 6, 2024 | Downs Christopher · officer: Chief Financial Officer | A-Award | 66,666 | $0.30 |
| Feb 6, 2024 | Downs Christopher · officer: Chief Financial Officer | Purchase | 66,666 | $0.30 |
| Feb 6, 2024 | Climaco John M · director, officer: Chief Executive Officer | A-Award | 166,666 | $0.30 |
| Feb 6, 2024 | Climaco John M · director, officer: Chief Executive Officer | Purchase | 166,666 | $0.30 |
Institutional positioning
13F filings over the trailing two quarters
New 8Increased 4Reduced 2Sold out 4
| Filer | Action | Shares | Filed |
|---|---|---|---|
| Ikarian Capital, LLC | Increased | 135,830 | Aug 14, 2026 |
| ADAR1 Capital Management, LLC | New Position | 70,000 | Aug 14, 2026 |
| STONEPINE CAPITAL MANAGEMENT, LLC | Increased | 61,000 | May 14, 2026 |
| IKARIAN CAPITAL, LLC | Unchanged | 45,830 | May 15, 2026 |
| Stonepine Capital Management, LLC | Reduced | 41,573 | Aug 17, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | New Position | 23,189 | May 15, 2026 |
| BOOTHBAY FUND MANAGEMENT, LLC | Unchanged | 13,524 | Aug 14, 2026 |
| BOOTHBAY FUND MANAGEMENT, LLC | Unchanged | 13,524 | May 15, 2026 |
| VANGUARD FIDUCIARY TRUST CO | New Position | 10,226 | Aug 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 6,993 | Aug 13, 2026 |
| UBS Group AG | Increased | 1,461 | Aug 13, 2026 |
| TOWER RESEARCH CAPITAL LLC (TRC) | New Position | 1,310 | May 15, 2026 |
| Tower Research Capital LLC (TRC) | Reduced | 799 | Aug 11, 2026 |
| UBS GROUP AG | Increased | 729 | May 5, 2026 |
| BARCLAYS PLC | New Position | 19 | Aug 14, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 18, 2026